Determination of physical viral vector titer in process development & QC for cell & gene therapy

This article emphasizes the importance of efficient analytics in the production of viral vectors for therapies, focusing on critical quality attributes such as vector titers and full-to-empty capsid ratios. It reviews analytical methods that support process development and QC, highlighting the role of the Gyrolab in overcoming the limitations of traditional methods through miniaturized, automated immunoassays.